original ) (raw )Salvage gamma knife stereotactic radiosurgery followed by bevacizumab for recurrent glioblastoma multiforme: a case–control study
John Flickinger
Journal of Neuro-Oncology, 2012
View PDFchevron_right
Survival effect of first- and second-line treatments for patients with primary glioblastoma: a cohort study from a prospective registry, 1997-2010
maria grazia bruzzone
Neuro-Oncology, 2014
View PDFchevron_right
Factors predictive of improved overall survival following stereotactic radiosurgery for recurrent glioblastoma
Sudheer Ambekar
Neurosurgical review, 2015
View PDFchevron_right
A clinical review of treatment outcomes in glioblastoma multiforme--thevalidation in a non-trial population of the results of a randomised PhaseIII clinical trial: has a more radical approach improved survival?
Mary Dunne
British Journal of Radiology, 2012
View PDFchevron_right
Chemoirradiation for Glioblastoma Multiforme: The National Cancer Institute Experience
Uma Shankavaram
PLoS ONE, 2013
View PDFchevron_right
Is re-radiation for glioblastoma after progression associated with increased survival: to treat or not to treat?
Santosh Kesari
Translational Cancer Research, 2019
View PDFchevron_right
Postprogression survival in patients with glioblastoma treated with concurrent chemoradiotherapy: a routine care cohort study
Nikhil Tanna
CNS oncology, 2017
View PDFchevron_right
Salvage stereotactic radiosurgery for recurrent glioblastoma multiforme with prior radiation therapy
Mark Bernard
Journal of Cancer Research and Therapeutics, 2016
View PDFchevron_right
Hypofractionated re-irradiation with bevacizumab for relapsed chemorefractory glioblastoma after prior high dose radiotherapy: a feasible option for patients with large-volume relapse
Venkatesha Venkatesha
Journal of Neuro Oncology, 2024
View PDFchevron_right
Retrospective and Randomized Analysis of Influence and Correlation of Clinical and Molecular Prognostic Factors in a Mono-Operative Series of 122 Patients with Glioblastoma Treated with STR or GTR
Santi Galletta
Brain Sciences, 2020
View PDFchevron_right
Clinical characterization of glioblastoma patients living longer than 2 years: A retrospective analysis of two Italian institutions
Cynthia Aristei
Asia-Pacific Journal of Clinical Oncology, 2020
View PDFchevron_right
Stereotactic Radiosurgery for Recurrent Glioblastoma Multiforme: A Retrospective Multi-Institutional Experience
Juliana Ramirez
Cureus, 2021
View PDFchevron_right
Survival after stereotactic radiosurgery of recurrent glioblastomas in patients with radical resection of primary tumor
Oksana Zemskova
Ukrainian Scientific Medical Youth Journal
View PDFchevron_right
Bevacizumab at first recurrence after standard radio-chemotherapy is associated with improved overall survival in glioblastoma patients with large tumor burden
Benjamin Ellingson
Neuro-Oncology Practice, 2018
View PDFchevron_right
Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients
Anne Bordron
Acta Neurochirurgica, 2007
View PDFchevron_right
Re-Irradiation and Its Contribution to Good Prognosis in Recurrent Glioblastoma Patients
jaejoon lim
Brain Tumor Research and Treatment
View PDFchevron_right
Short Course versus Standard Course of Radiotherapy in Glioblastoma Multiforme
Amr Sakr
Journal of Nuclear Medicine & Radiation Therapy, 2018
View PDFchevron_right
Adjuvant re-irradiation vs. no early re-irradiation of resected recurrent glioblastoma: pooled comparative cohort analysis from two tertiary centers
Christoph Straube
Journal of neuro-oncology, 2024
View PDFchevron_right
Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme
Eben Alexander III
International Journal of Radiation Oncology*Biology*Physics, 1994
View PDFchevron_right
Radiotherapy is effective in patients with glioblastoma multiforme with a limited prognosis and in patients above 70 years of age: A retrospective single institution analysis
Joan Voormolen
Radiotherapy and Oncology, 2005
View PDFchevron_right
Gamma knife radiosurgery for local recurrence of glioblastoma
Roman Liscak
PubMed, 2018
View PDFchevron_right
Concurrent Stereotactic Radiosurgery and Bevacizumab in Recurrent Malignant Gliomas: A Prospective Trial
Annick Desjardins
International Journal of Radiation Oncology*Biology*Physics, 2013
View PDFchevron_right
Prognostic Factors for Glioblastoma Multiforme: Development of a prognostic index
Didem Karacetin
Acta Oncologica, 1996
View PDFchevron_right
Radiosurgery for recurrent glioblastoma: a review article
Bahar Dirican
Neurological Disorders and Therapeutics, 2017
View PDFchevron_right
Recurrent Glioblastoma Management Using Stereotactic Radiosurgery and Systemic Treatment
Oksana Zemskova
Technology transfer: innovative solutions in medicine
View PDFchevron_right
Radiosurgery in the initial management of malignant gliomas: Survival comparison with the RTOG recursive partitioning analysis
Timothy Kinsella
International Journal of Radiation Oncology*Biology*Physics, 1995
View PDFchevron_right
Progression types after antiangiogenic therapy are related to outcome in recurrent glioblastoma
Georg Göbel
Neurology, 2014
View PDFchevron_right
Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme
Carl Langberg , Eirik Helseth
Acta Neurologica Scandinavica, 2010
View PDFchevron_right
Prognostic factors for survival of patients with glioblastoma: Recursive partitioning analysis 1
Michael Prados
2000
View PDFchevron_right
Survival after Stereotactic Radiosurgery for Recurrent Glioblastoma Multiforme
David Peereboom
2000
View PDFchevron_right
The role of salvage reirradiation for malignant gliomas that progress on bevacizumab
Joseph Anderson
Journal of Neuro-Oncology, 2009
View PDFchevron_right
Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis
Julie Hammack
Journal of Neuro-Oncology, 2020
View PDFchevron_right
Survival impact of prolonged postoperative radiation therapy for patients with glioblastoma treated with combined-modality therapy
Shiao Woo
Neuro-Oncology Practice, 2018
View PDFchevron_right
Prognostic factors in patients with glioblastoma multiforme (clinical research)
Ali KURTSOY
TURKISH JOURNAL OF MEDICAL SCIENCES, 2013
View PDFchevron_right
Treatment options for recurrent glioblastoma: pitfalls and future trends
Stefania Bartolini
Expert Review of Anticancer Therapy, 2009
View PDFchevron_right